Ground was broken yesterday for Bridgeside Point II, a new $65 million research facility at The Pittsburgh Technology Center in
Hazelwood.
Located at 450 Technology Dr. next to the
University of Pittsburgh Biotech Center, the 150,000 square-foot development will house wet lab facilities and offices. The project is being developed by Cleveland-based
Ferchill Group, whose proposal for the five-story building was approved by the
URA board in February. The specialized lab facility is expected to create up to 400 jobs.
To support the project, the URA is investing $19 million in infrastructure work, including a new 750-space parking garage, roadway improvements and utility placement. Future plans for the technology center may call for mixed-use and hotel developments. Project architect is Downtown-based
Strada; contractor is
Turner Construction Company, who also built Bridgeside Point I, a 153,000 square-foot lab facility at The Pittsburgh Technology Center. Fully leased, the property serves as
Cellomics’ headquarters.
Prompted by the success of Bridgeside Point I, Bridgeside Point II is expected to meet the needs of local universities and medical centers who have
identified a need for additional laboratory space. The Ferchill Group
feels that the demand for quality lab space in
locations near Pittsburgh’s academic and medical institutions will result in more than one-million square feet over the next three to
five years. Ferchill, who also developed the Cellomics building and
Heinz Lofts, has the option to build an adjacent, 120,000 square-foot
facility once Bridgeside Point II is 50% leased.
Construction on Bridgeside Point II is slated to take 15 months.
Writer:
Jennifer BaronSource: Joanna Doven, Office of the Mayor, City of Pittsburgh
Image Courtesy of The Ferchill Group/Strada